4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-24-083401
Chief Executive Officer sold 20,293 shares at $5.97 ($121,218)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2024-07-11 | Sale | −20,293 | $5.97 | $121,218 | 353,263 | D |
| Open-market sales · 20,293 sh · avg $5.97 · $121,218 | |||||||
Loading xslF345X05/ownership.xml…